Skip to content

Dortmund, 17th January 2025

Portrait von Lennart Kowitz.
© ISAS

In addition to his role as a software engineer, Lennart Kowitz is also a member of the works council at ISAS.

Lennart Kowitz joined ISAS in 2017 as an IT specialist-trainee. Today, he works here as a software engineer in the AMBIOM – Analysis of Microscopic BIOMedical Images research group and is involved in the works council. The 27-year-old is also studying computer science at TU Dortmund University. To find out more about his work in the ISAS research group, the editorial team asked him to complete the following sentences.

  • At ISAS I work…

    on making AI methods accessible to biomedical researchers. In other words, I make sure that they can use the AMBIOM tools without extensive programming knowledge. Moreover, I take care of cluster management in our research group. A cluster is a group of computers that are particularly suited for calculations. My IT experience also allows me to act as an interface between our team and the IT department at ISAS.

  • After my IT training, I stayed at the institute because...

    I wanted to maintain my work rhythm at first. During my training, I learnt to structure my (working) day. After completing my IT training, I initially worked in administration at ISAS. As I had previously felt very comfortable in IT, I toyed with the idea of returning there later. In the end, however, things turned out differently: ISAS set up an AI research group for analysing biomedical microscope images, for which I then applied internally.

  • What particularly fascinates me about my work...

    is the interplay of expertise: We have the skills of our AI experts on the one hand and our end users from biomedical research on the other. For me, software development is the most abstract thing there is. It is hard to visualise software itself, it is not tangible. That makes it very fascinating to deal with and to find out how I can develop good software for the scientists in the lab. This is a journey I have been on for three and a half years. And fortunately, with so many approaches, ideas and concepts in circulation at AMBIOM, it is not going to end any time soon.

  • I am involved in the works council because...

    I think it is important to represent the interests of all employees. I also have the opportunity to learn a lot at training courses, for example on labour law, which I can use to support my colleagues. I also really appreciate the dialogue with the works councils from other Leibniz Institutes.

Share

Further articles

3 Questions for Neele Rottmann

In the lab, Neele Rottmann prepares human and animal samples for mass spectrometry analysis. As part of the HI-FIVE project, she is helping to identify changes at the protein level in heart failure. Why does she spend so much time in the lab working on separations? The technical assistant shares the answer in this interview.

Neele Rottmann is wearing a white lab coat and purple gloves and is operating a mass spectrometry analyser in a laboratory. Next to her is a liquid chromatography system connected to a mass spectrometer via several tubes. There are numerous sample vials on the instrument. As she places a sample into the system, she looks into the camera.

High-tech against Cardiovascular Diseases: 3D Images of Blood Vessels

How do atherosclerotic plaques form in the coronary arteries? At ISAS, researchers are investigating cellular changes in human coronary arteries using techniques such as 3D imaging. During her internship, early-career researcher Leonie Menzel used a light sheet fluorescence microscope to analyse the spatial distribution of individual cells within the tissue. She thereby gained valuable methodological experience for her Master’s thesis.

3 Questions for Lukas Fu

How can AI support the analysis of biomedical images? This was the question Lukas Fu explored during his school internship at ISAS. The 15-year-old also successfully completed his first programming project.

Lukas Fu, a 15-year-old with short black hair. He is wearing glasses and is sitting on a low wall.

Separating Fluorescence Signals Faster and More Precisely with AI

When different fluorescence signals overlap during microscopy, their clear assignment to specific biological structures becomes difficult. To address this common problem, Dr Davide Panzeri is developing AI-based signal separation methods. The biophysicist has been awarded a Marie Skłodowska-Curie Fellowship by the European Union for his promising research project.

Porträt Dr. Davide Panzeri.

Passionate Research, Shaping the Future

How do GRK5 inhibitors work at the cellular level and within the living organism? Biologist Dr Susanne Grund is working with her colleagues at HI-FIVE on a new therapeutic approach for heart failure. In this portrait, she describes what her day-to-day work looks like, balancing research on human stem cells with studies on mice.

ISAS BFF Uploader

What are you doing at ISAS, Theresa?

Why do mice undergo ultrasound examinations of their hearts? What does a typical working day in the lab involve for a technical assistant in the HI-FIVE research project ? And what challenges does the job present? Theresa Pietz provides fascinating insights into her duties, motivations and experiences working with animals.

Study with Heart: A Doctor Bridging Clinic & Laboratory

What is actually happening behind the scenes of a patient trial? Anna Ruzhyna is a clinical research associate who looks after participants with heart failure as part of the HI-FIVE project. She explains how her work helps to develop new therapeutic approaches for the treatment of heart failure.

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.